Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 1ADC Therapeutics

02 2Swedish Orphan Biovitrum AB

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

Pharma MES 2025
Not Confirmed
arrow
arrow
Pharma MES 2025
Not Confirmed

LONCASTUXIMAB TESIRINE-LPYL

Brand Name : ZYNLONTA

Dosage Form : INJECTABLE;INJECTION

Dosage Strength : 10MG

Packaging :

Approval Date :

Application Number : 761196

Regulatory Info :

Registration Country : USA

blank

02

Pharma MES 2025
Not Confirmed
arrow
arrow
Pharma MES 2025
Not Confirmed

Lonkastuximabtesirin

Brand Name : Zynlonta

Dosage Form : Powder For Concentrate For Solution For Infusion

Dosage Strength : 10mg

Packaging :

Approval Date : 20/12/2022

Application Number : 20211007000014

Regulatory Info : Approved

Registration Country : Sweden

blank

03

Pharma MES 2025
Not Confirmed
arrow
arrow
Pharma MES 2025
Not Confirmed

Loncastuximab Tesirine

Brand Name : Zynlonta

Dosage Form : Powder For Concentrate For Infusion Solution

Dosage Strength : 10MG

Packaging :

Approval Date : 2023-05-08

Application Number : 1221695001

Regulatory Info : Authorized

Registration Country : Spain

blank